Life Healthcare HEPS from cont. ops +59% to 139c beating the BB consensus of 114c | Revenue +12.7% to R25.5bn, driven by growth in southern Africa and NeuraCeq sales (an imaging agent used in PET scans) | Paid patient days in acute hospitals +1.6% | Disposals enabled a special divi of 600c in April & Net debt to EBITDA reduced to 0.45x from 2.0x in FY23 | Final div +14.8% to 31 cents, with an additional special dividend of 70 cents.
Click here to read the SENS

Join our Mailing list!
Sign up to get all the latest financial news and business updates.

Subscribe to fund newsletter

Please fill in the form and we will get in touch with you shortly and help answer any questions you may have about Offshore Supporting services.